IJCS | Volume 31, Nº3, May/ June 2018

314 Figure 2 – Cardiovascular magnetic resonance shows increased left ventricular volume and wall thickness on cine images acquired in 4-chamber (A), long axis (2-chambers) (B) and medial short axis (C) views. Diffuse and transmural late gadolinium enhancement is showed (D, E, F) with preservation of basal segments. (G) Endomyocardial biopsy showed myocyte disarray. 1. Task Force Members. Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014; 35(39): 2733–79. DOI: 10.1093/euheartj./Orgv-Ejehu284. 2. Lipshultz SE, Sleeper LA, Towbin JA, lowe AM, Cox GF, Lurie PR, et al. The incidence of pediatric cardiomyopathy in two regions of the United States. NEngl J Med. 2003;348(17):1647-55. DOI: 10.1056/NEJM.oa21715. 3. Ho CY, Charron P, Richard P, Garolami F, Van Spaendonck-Zwarts KY, Pinto Y. Genetic advances in sarcomeric cardiomyopathies: state of the art. Cardiovasc Res 2015; 105: 397–408. DOI: 10.1093/ cv/cvv025. 4. Anan R, ShonoH, Kisanuki A, Arima S, Nakao S, Tanaka H. et al. Patients with familial hypertrophiccardiomyopathy caused by a Phe110Ile missense mutation in the cardiactroponin T gene have variable cardiac morphologies and a favorableprognosis. Circulation. 1998;98(5):391–7. PMID:9714088. References Arias et al. Hypertrophic cardiomyopathy International Journal of Cardiovascular Sciences. 2018;31(3)312-315 Case Report